Literature DB >> 8121628

Resiniferatoxin-induced loss of vanilloid receptors is reversible in the urinary bladder but not in the spinal cord of the rat.

C Goso1, G Piovacari, A Szallasi.   

Abstract

Resiniferatoxin (RTX) induced a dose-dependent loss of vanilloid receptors (specific [3H]RTX-binding sites) in tissues containing peripheral (urinary bladder) and central (spinal cord) endings of capsaicin-sensitive neurons. This receptor loss in the spinal cord was entirely due to a reduction in the Bmax. When examined 24 h after s.c. RTX treatment, receptor loss required somewhat less RTX in the urinary bladder (ED50 = 10 micrograms/kg) than in the spinal cord (ED50 = 50 micrograms/kg), whereas the loss of the xylene-induced neurogenic inflammatory response in the bladder displayed an approximate ED50 of 5 micrograms/kg. In the bladder of rats pretreated with 30 micrograms/kg RTX, both receptor binding and neurogenic inflammatory response recovered almost completely within 2 month after treatment. In the bladder of rats that received a 10-fold higher RTX dose, a 50% recovery of binding and a 70% recovery of the Evans' blue extravasation response were found. By contrast, no recovery of specific [3H]RTX binding to spinal cord membranes was observed at either dose. These findings suggest that vanilloid receptor loss after RTX treatment can be either reversible (desensitization) or irreversible (most likely reflecting neurotoxicity), and that peripheral and central terminals of capsaicin-sensitive neurons have a differential sensitivity to these long-term vanilloid actions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8121628     DOI: 10.1016/0304-3940(93)90594-b

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

1.  Forced swim-induced musculoskeletal hyperalgesia is mediated by CRF2 receptors but not by TRPV1 receptors.

Authors:  Ramy E Abdelhamid; Katalin J Kovacs; Jeffrey D Pasley; Myra G Nunez; Alice A Larson
Journal:  Neuropharmacology       Date:  2013-04-25       Impact factor: 5.250

2.  TRPV1-Targeted Drugs in Development for Human Pain Conditions.

Authors:  Mircea Iftinca; Manon Defaye; Christophe Altier
Journal:  Drugs       Date:  2021-01       Impact factor: 9.546

3.  Differential effects of intravesical resiniferatoxin on excitability of bladder spinal neurons upon colon-bladder cross-sensitization.

Authors:  Anna P Malykhina; Chao Qin; Qi Lei; Xiao-Qing Pan; Beverley Greenwood-Van Meerveld; Robert D Foreman
Journal:  Brain Res       Date:  2012-11-09       Impact factor: 3.252

4.  Capsaicin-Sensitive Peptidergic Sensory Nerves Are Anti-Inflammatory Gatekeepers in the Hyperacute Phase of a Mouse Rheumatoid Arthritis Model.

Authors:  Bálint Botz; Gábor Kriszta; Kata Bölcskei; Ádám István Horváth; Attila Mócsai; Zsuzsanna Helyes
Journal:  Int J Mol Sci       Date:  2021-02-08       Impact factor: 5.923

5.  Selective targeting of TRPV1 expressing sensory nerve terminals in the spinal cord for long lasting analgesia.

Authors:  Joseph A Jeffry; Shuang-Quan Yu; Parul Sikand; Arti Parihar; M Steven Evans; Louis S Premkumar
Journal:  PLoS One       Date:  2009-09-15       Impact factor: 3.240

6.  Desensitization of Capsaicin-Sensitive Afferents Accelerates Early Tumor Growth via Increased Vascular Leakage in a Murine Model of Triple Negative Breast Cancer.

Authors:  Noémi Bencze; Csaba Schvarcz; Gábor Kriszta; Lea Danics; Éva Szőke; Péter Balogh; Árpád Szállási; Péter Hamar; Zsuzsanna Helyes; Bálint Botz
Journal:  Front Oncol       Date:  2021-07-14       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.